Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission

Clinical trial NCT07507318 · RECRUITING

Trial details

NCT number: NCT07507318
Sponsor: Rong Tao
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma

Start date: 2026-06-16
Primary completion: 2029-06-30
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.